> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Breakthrough Designation for Renew Cerezen
- URL: https://www.fdaweb.com/breakthrough-designation-for-renew-cerezen/
- Published: 2021-11-02T12:00:00.000Z
- Updated: 2026-09-14T17:21:04.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5150497

FDA has granted breakthrough device designation to Renew Bioscience’s Cerezen device, described as a novel treatment for mild cognitive impairment due to Alzheimer’s disease and mild dementia of the Alzheimer’s type. The company [says](http://email.prnewswire.com/ls/click?upn=1wail4kuE335JAITe4Fv8sh3b45qtZNufu6hsx-2Bkl7Z-2FCPULN8MfHGVZ0I2D6i-2FET10Q7FvuFNhtSKTyvljeBFLvlJa8NiraBwjKU-2FtZiffQtbij9bSdJ-2FZQmqjIdNab1hUNGqpRJS2G0iy5LjhqHaMbjFl04OCDnma7Nx3Q-2BmI-3DJE%5FI%5Ff0D7hj0BJ4b-2F7NuVqzPDs7FGiq8VLIwAX0sPSotqoLJejYqb1dmQHyCXe45PgGWVh2fxUcYMn4cK70DKDul2UgjcXhs-2ByPCS0I0EqzjC74LplboG9awEK9IX6Do3l6bmXqhYhE3KohblgMobW2Jt6NyFupb3aMCx7aX4VS-2B4rJKW7x8XQJnvyT4tUzaXnBi3UjbUUftyOytHh-2BbaxNCI2naJ59S3i-2FF7EfVuOkBREoPc5kvOsgJTX8Kc4zOkT17D4q3dvjNc0VTw8PNdtH4NpUJnw0qLecbtE-2FITSkpsLSaC3JkxiD1OEJkWVzU62jHWlcEFiLAsdW9IhNc4U0Ojfw-3D-3D&ref=fdaweb.com) the device is a drug-free, non-invasive technology designed to improve cerebral vascular health by enhancing circulation, stimulating the physiological effects of vigorous exercise, and stimulating endothelial cell function through a series of treatment sessions.